GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™

POTENTIAL TREATMENT OF SEVERAL SOLID TUMOR CANCERS INCLUDING: NON-SMALL CELL LUNG CANCER,…